| Emily Jean Robinson, DO | |
|
710 Center St, Columbus, GA 31901-1527 | |
| (706) 571-1000 | |
| Not Available |
| Full Name | Emily Jean Robinson |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 710 Center St, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366976102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 85974 (Georgia) | Secondary |
| 207P00000X | Emergency Medicine | S2483 (Texas) | Secondary |
| 207P00000X | Emergency Medicine | DR.0069735 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Colorado Medical Center | Greeley, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Professionals Of Colorado Pc | 2860706967 | 38 |
News Archive
BioSante Pharmaceuticals, Inc., today announced it sold to Cold Genesys, Inc. exclusive, worldwide rights to develop and commercialize its oncolytic virus technology. The technology includes CG0070, a replication-competent adenovirus that has completed a Phase I clinical trial for treatment of superficial bladder cancer. In exchange for the technology, BioSante received a 19.9 percent ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and royalty payments.
Cancer is one of the most thought-provoking healthcare problems throughout the world. The development of therapeutic agents with highly selective anti-cancer activities is increasingly attractive due to the lack of tumor selectivity of conventional treatments.
Bioengineers have created three-dimensional brain-like tissue that functions like and has structural features similar to tissue in the rat brain and that can be kept alive in the lab for more than two months.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, "Type 2 Diabetes and Hearing Impairment" in the journal, Current Diabetes Reports.
After a sports-related concussion, traditional recovery recommendations have previously called for weeks or months of rest, depending on the duration of a person's symptoms.
› Verified 9 days ago
| Entity Name | Emergency Professionals Of Colorado Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396496469 PECOS PAC ID: 2860706967 Enrollment ID: O20150803002325 |
News Archive
BioSante Pharmaceuticals, Inc., today announced it sold to Cold Genesys, Inc. exclusive, worldwide rights to develop and commercialize its oncolytic virus technology. The technology includes CG0070, a replication-competent adenovirus that has completed a Phase I clinical trial for treatment of superficial bladder cancer. In exchange for the technology, BioSante received a 19.9 percent ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and royalty payments.
Cancer is one of the most thought-provoking healthcare problems throughout the world. The development of therapeutic agents with highly selective anti-cancer activities is increasingly attractive due to the lack of tumor selectivity of conventional treatments.
Bioengineers have created three-dimensional brain-like tissue that functions like and has structural features similar to tissue in the rat brain and that can be kept alive in the lab for more than two months.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, "Type 2 Diabetes and Hearing Impairment" in the journal, Current Diabetes Reports.
After a sports-related concussion, traditional recovery recommendations have previously called for weeks or months of rest, depending on the duration of a person's symptoms.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Jean Robinson, DO 370 Serenity Loop, Cataula, GA 31804-2368 Ph: (330) 705-7749 | Emily Jean Robinson, DO 710 Center St, Columbus, GA 31901-1527 Ph: (706) 571-1000 |
News Archive
BioSante Pharmaceuticals, Inc., today announced it sold to Cold Genesys, Inc. exclusive, worldwide rights to develop and commercialize its oncolytic virus technology. The technology includes CG0070, a replication-competent adenovirus that has completed a Phase I clinical trial for treatment of superficial bladder cancer. In exchange for the technology, BioSante received a 19.9 percent ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and royalty payments.
Cancer is one of the most thought-provoking healthcare problems throughout the world. The development of therapeutic agents with highly selective anti-cancer activities is increasingly attractive due to the lack of tumor selectivity of conventional treatments.
Bioengineers have created three-dimensional brain-like tissue that functions like and has structural features similar to tissue in the rat brain and that can be kept alive in the lab for more than two months.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, "Type 2 Diabetes and Hearing Impairment" in the journal, Current Diabetes Reports.
After a sports-related concussion, traditional recovery recommendations have previously called for weeks or months of rest, depending on the duration of a person's symptoms.
› Verified 9 days ago
Dr. Jonathan Thomas, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8400 Veterans Pkwy Apt 814, Columbus, GA 31909 Phone: 814-504-4211 | |
Dr. Jacqueline Akua Owusu, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2022 10th Ave Ste B, Columbus, GA 31901 Phone: 706-507-9407 Fax: 706-507-9408 | |
Mr. David P. Smith, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expressway, Columbus, GA 31904 Phone: 706-596-4000 | |
John R Corbin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expressway, Columbus, GA 31904 Phone: 706-596-4000 | |
Dr. Kennon A Mclendon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 Center St, Columbus, GA 31901 Phone: 706-571-1200 | |
Michael David Hagues, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2122 Manchester Expressway, Columbus, GA 31904 Phone: 706-596-4000 | |
Gehrig Leonard Harris Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7093 Haddonfield Ct, Columbus, GA 31904 Phone: 337-336-0423 |